Clinical evaluation of glipizide in patients with diabetes mellitus

References

• Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs. Part I. Arzneim-forsch 1971; 21: 2001. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs. Part I. Arzneim-forsch 1971; 21: 200
   Web of Science ®Google Scholar
• Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs. Part II. Arzneim-forsch 1971; 21: 2042. Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs. Part II. Arzneim-forsch 1971; 21: 204
   Web of Science ®Google Scholar
• Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study of a new oral antidiabetic: N-{ 4-[D-(5-methylpyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexylurea or K 4024. Arzneim.-forsch 1971; 21: 2083. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study of a new oral antidiabetic: N-{ 4-[D-(5-methylpyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexylurea or K 4024. Arzneim.-forsch 1971; 21: 208
   Web of Science ®Google Scholar
• Ambrogi V., Bloch K., Daturi S., Logemann W., Parenti M. A., Tommashi R. New oral antidiabetic drugs. Part III. Arzneim.-forsch 1972; 22: 5424. Ambrogi V., Bloch K., Daturi S., Logemann W., Parenti M. A., Tommashi R. New oral antidiabetic drugs. Part III. Arzneim.-forsch 1972; 22: 542
   PubMed Web of Science ®Google Scholar
• Angeli G., Baraldi B., Tiraboschi L., Caputo G. Un nuovo ipoglicemizzante orale: K 4024 o glipizide. Sperimentazione clinica. Clin. ter 1972; 63: 4375. Angeli G., Baraldi B., Tiraboschi L., Caputo G. Un nuovo ipoglicemizzante orale: K 4024 o glipizide. Sperimentazione clinica. Clin. ter 1972; 63: 437
   Google Scholar
• Domingo Gutierrez A. J., Fernandez-Cruz A. Efecto hipoglucemiante e insulinoliberador de la glipizida. Comunicación a la IX Reunión Hispano-Lusa de Endocrinologia. Sevilla, Spain 1972; 9–11, October 1972.6. Domingo Gutierrez A. J., Fernandez-Cruz A. Efecto hipoglucemiante e insulinoliberador de la glipizida. Comunicación a la IX Reunión Hispano-Lusa de Endocrinologia. Sevilla, Spain 1972; 9–11, October 1972.
   Google Scholar
• Dorningo Gutierrez A. J., Fernandez-Cruz A. Clinical evaluation of glipizide, a new oral hypoglycaemic agent. Rev. Ibér. Endocr 1973; 20: 2897. Dorningo Gutierrez A. J., Fernandez-Cruz A. Clinical evaluation of glipizide, a new oral hypoglycaemic agent. Rev. Ibér. Endocr 1973; 20: 289
   PubMedGoogle Scholar
• d'Onofrio F., Pempinello R., Romis L. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide. Arzneim-forsch 1972; 22: 18798. d'Onofrio F., Pempinello R., Romis L. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide. Arzneim-forsch 1972; 22: 1879
   PubMed Web of Science ®Google Scholar
• Dubowski K. M. An o-toluidine method for body fluid glucose determination. Clin. Chem 1962; 8: 2159. Dubowski K. M. An o-toluidine method for body fluid glucose determination. Clin. Chem 1962; 8: 215
   PubMed Web of Science ®Google Scholar
• Fedele D., Tiengo A., Riva F., Muggeo M., Emanueli A., Crepaldi G. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024). Arzneim.-forsch 1972; 22: 188510. Fedele D., Tiengo A., Riva F., Muggeo M., Emanueli A., Crepaldi G. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024). Arzneim.-forsch 1972; 22: 1885
   PubMed Web of Science ®Google Scholar
• Greco A. V., Fedeli G., Ghirianda G., Lucente M., Accietto F., Fenici R. Esperienze cliniche sull'azione di un nuovo antidiabetico orale: la glidiazinamide. Minerva med 1971; 62: 282911. Greco A. V., Fedeli G., Ghirianda G., Lucente M., Accietto F., Fenici R. Esperienze cliniche sull'azione di un nuovo antidiabetico orale: la glidiazinamide. Minerva med 1971; 62: 2829
   PubMedGoogle Scholar
• Hales C. N., Randle P. J. Immuno-assay of insulin with insulin-antibody precipitate. Biochem. J 1963; 88: 13712. Hales C. N., Randle P. J. Immuno-assay of insulin with insulin-antibody precipitate. Biochem. J 1963; 88: 137
   PubMed Web of Science ®Google Scholar
• Marigo S., del Nevo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim-forsch 1971; 21: 21513. Marigo S., del Nevo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim-forsch 1971; 21: 215
   Web of Science ®Google Scholar
• Parodi F. A. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Israel J. med. Sci 1972; 8: 88814. Parodi F. A. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Israel J. med. Sci 1972; 8: 888
   PubMedGoogle Scholar
• Pedrazzi F., Pisani Ceretti A., Losi S., Bommartini F., Artini D., Emanueli A. Evaluation in hospitalized subjects of anew hypoglycemic sulphonylurea, glydiazinamide. Arzneim.-forsch 1971; 21: 22015. Pedrazzi F., Pisani Ceretti A., Losi S., Bommartini F., Artini D., Emanueli A. Evaluation in hospitalized subjects of anew hypoglycemic sulphonylurea, glydiazinamide. Arzneim.-forsch 1971; 21: 220
   Web of Science ®Google Scholar
• Pedrazzi F., Bommartini F. Clinical evaluation of glidiazinamide. Giorn. Geront 1972; 20: 45916. Pedrazzi F., Bommartini F. Clinical evaluation of glidiazinamide. Giorn. Geront 1972; 20: 459
   PubMedGoogle Scholar
• Siegel S. “Non-parametric Statistics for the Behavioral Sciences”. McGraw-Hill, New York 195617. Siegel S. “Non-parametric Statistics for the Behavioral Sciences”. McGraw-Hill, New York 1956
   Google Scholar
• Vailati G., Pagani G., Montini M., Caputo G., Sacchetti G. Effect of glipizide on a double-meal test in diabetic patients. Arzneim-forsch 1972; 22: 188818. Vailati G., Pagani G., Montini M., Caputo G., Sacchetti G. Effect of glipizide on a double-meal test in diabetic patients. Arzneim-forsch 1972; 22: 1888
   PubMed Web of Science ®Google Scholar